Home / Atorvastatin / Czechia
CZ ATC C10AA05 · updated 2 Nov 2026
Atorvastatin shortage in Czechia
Is there an Atorvastatin shortage in Czechia?
Yes. As of 2 Nov 2026, 5 Atorvastatin products are reported short in Czechia, the first since 10 Sep 2026. The company estimate for the return is 6 Nov 2026 (latest 30 Sep 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, Italy, Spain, Ireland, Austria, Belgium, Norway, Sweden, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | SORTIS 80MG 80MG TBL FLM 30 | VIATRIS HEALTHCARE LIMITED, Dublin | 10 Sep 2026 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | ATORVASTATIN RATIOPHARM 40MG 40MG TBL FLM 90 I | Teva B.V., Haarlem | 28 Sep 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | TORVACARD NEO 40MG 40MG TBL FLM 30 | Zentiva, k.s., Praha | 5 Oct 2026 | 6 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | ATORVASTATIN MEDREG 20MG 20MG TBL FLM 90 | MEDREG s.r.o., Praha | 19 Oct 2026 | 30 Sep 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | TORVACARD NEO 60MG 60MG TBL FLM 30 anticipated | Zentiva, k.s., Praha | 30 Nov 2026 | 15 Jan 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.